Priority Date: 12.07.12 (CN 20121240697)

CRYSTALLINE FORM I OF TYROSINE KINASE INHIBITOR DIMALEATE AND PREPARATION METHODS THEREOF

  • Application ID: EP13817593
  • Status: The patent has been granted

Attorney

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 192 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 12.07.2012 - Priority Date (CN 20121240697)
  • 16.01.2014 - Publication A1 (WO2014008794)
  • 20.05.2015 - Publication A1 (EP2873664)
  • 01.11.2017 - Publication B1 (EP2873664)

IPC Classification